2-201491224-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001168221.2(C2CD6):c.5117T>A(p.Leu1706Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000433 in 1,385,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD6 | NM_001168221.2 | c.5117T>A | p.Leu1706Gln | missense_variant | 15/16 | ENST00000439140.6 | NP_001161693.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD6 | ENST00000439140.6 | c.5117T>A | p.Leu1706Gln | missense_variant | 15/16 | 1 | NM_001168221.2 | ENSP00000409937.1 | ||
C2CD6 | ENST00000286195.7 | c.1582-3322T>A | intron_variant | 1 | ENSP00000286195.3 | |||||
C2CD6 | ENST00000439802.5 | c.*50-3322T>A | intron_variant | 2 | ENSP00000400672.1 | |||||
C2CD6 | ENST00000482942.1 | n.101-3322T>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 4AN: 144138Hom.: 0 AF XY: 0.0000522 AC XY: 4AN XY: 76640
GnomAD4 exome AF: 0.00000433 AC: 6AN: 1385454Hom.: 0 Cov.: 33 AF XY: 0.00000585 AC XY: 4AN XY: 683620
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.5117T>A (p.L1706Q) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a T to A substitution at nucleotide position 5117, causing the leucine (L) at amino acid position 1706 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at